Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.

Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW.

Genes Dev. 2008 Jun 1;22(11):1439-44. doi: 10.1101/gad.1672608.

2.
3.

Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.

Di Benedetto M, Pineau P, Nouet S, Berhouet S, Seitz I, Louis S, Dejean A, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Nahmias C.

Mol Cell Endocrinol. 2006 Jun 27;252(1-2):207-15. Epub 2006 May 2. Review.

PMID:
16650523
4.

[Loss of heterozygosity in hepatocellular carcinoma].

Takahashi K, Kudo J, Ishibashi H, Niho Y.

Nihon Rinsho. 1993 Feb;51(2):370-4. Review. Japanese.

PMID:
8096550
5.

Regulation of gene expression in hepatomas.

Lea MA.

Int J Biochem. 1993 Apr;25(4):457-69. Review. No abstract available.

PMID:
8385634
6.

Hepatocellular carcinoma: molecular and genomic guideline for the clinician.

Frenette C, Gish RG.

Clin Liver Dis. 2011 May;15(2):307-21, vii-x. doi: 10.1016/j.cld.2011.03.010. Review.

PMID:
21689615
7.

Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Popescu NC, Goodison S.

Mol Diagn Ther. 2014 Jun;18(3):293-302. doi: 10.1007/s40291-014-0086-3. Review.

Supplemental Content

Support Center